Work

S2477 Limited Approvals in MASLD Highlight the Need to Reevaluate FDA Guidance for Outcome Measures

Year: 2025
Type: conference-abstract
Language: English
Subfield: Epidemiology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417237703
Cites:
Cited by:
Related to: